TABLE 2.
Lead moleculesa | QP log Po/wb | QP log Sc | Mrd | QP log HERGe | No. of metabf | HAg | HDh | Human oral absorptioni |
---|---|---|---|---|---|---|---|---|
% | ||||||||
MB22184 | 2.042 | −2.586 | 203.1 | −4.103 | 3 | 1.7 | 1.0 | 60.2 |
MB9055 | 1.828 | −1.647 | 226.2 | −4.384 | 2 | 3.7 | 1.0 | 59.3 |
MB16877 | −0.937 | −0.252 | 166.1 | −1.810 | 4 | 5.2 | 1.0 | 61.7 |
MB16695 | 0.865 | −2.194 | 230.2 | −5.264 | 2 | 6.0 | 3.0 | 80.1 |
MB2306 | 0.615 | −2.953 | 279.3 | −5.085 | 1 | 6.9 | 3.0 | 67.5 |
MB21833 | −0.280 | −1.064 | 200.1 | −1.366 | 2 | 3.7 | 2.0 | 37 |
MB22680 | 1.439 | −2.113 | 183.1 | −3.818 | 4 | 2.7 | 1.0 | 77.3 |
MB14654 | −0.766 | −0.017 | 157.1 | −1.417 | 3 | 3.5 | 2.0 | 55.99 |
ZINC05818427 | 0.957 | −1.12 | 175.2 | −4.838 | 6 | 2.5 | 3.0 | 78.1 |
ZINC20351904 | 2.478 | −3.196 | 302.8 | −5.978 | 1 | 5.5 | 1.5 | 80 |
ZINC12530372 | 0.185 | −0.933 | 195.2 | −4.444 | 3 | 5.5 | 1.0 | 70 |
ZINC08733382 | 1.154 | −1.000 | 234.3 | −5.234 | 2 | 4.5 | 2.0 | 59 |
ZINC15076564 | 1.802 | −2.185 | 328.4 | −3.594 | 2 | 7.2 | 2.0 | 73.2 |
ZINC05818387 | 0.756 | −0.969 | 175.2 | −4.830 | 4 | 2.5 | 3.0 | 72.3 |
ZINC21953304 | 0.849 | −0.966 | 175.2 | −4.513 | 3 | 2.5 | 3.0 | 76.2 |
ZINC35233532 | −0.523 | −0.383 | 228.2 | −0.858 | 2 | 7.2 | 2.0 | 66.1 |
ZINC32110629 | 1.977 | −1.791 | 258.3 | −4.052 | 4 | 2.75 | 1.0 | 79.1 |
a Ligand IDs are of the Maybridge database and ZINC database.
b Predicted octanol/water partition co-efficient log P (acceptable range, −2.0 to 6.5).
c Predicted aqueous solubility; S in mol/liter (acceptable range, −6.5 to 0.5).
d Molecular weight (<500).
e Predicted IC50 value for blockage of HERG K+ channels (acceptable range, below −5.0).
f Number of metabolic reactions (from 1 to 8).
g Hydrogen bond acceptors (<10).
h Hydrogen bond donors (<5).
i Percentage of human oral absorption <25% is poor and >80% is high).